Immunome has developed a technology that rapidly and productively discovers new cancer therapies by harnessing the immune system.
- Stage Product In Development
- Industry Biotechnology
- Location Philadelphia, PA, USA
- Currency USD
- Founded February 2008
- Employees 4
- Website immunomeinc.com
Immunome is a biotechnology company that uses its proprietary technology and processes to discover and develop new cancer therapies using a totally new approach. We leverage our technology and investment through industry partnerships that provide non-dilutive capital while we develop maximum value and the product potential that leads to exit opportunities with these same partners.
Joan Lau is Managing Partner of Militia Hill Ventures and COO of Immunome Inc. She has served as president and CEO with several venture-backed biotechnology companies including Azelon and Locus Pharmaceuticals. Prior to Locus, Dr. Lau worked at Merck & Co, in leadership roles within R&D drug development and business development.
Jane Holmes HollingsworthExecutive Chair
Jane is Managing Partner of Militia Hill Ventures and co-founder and former CEO of NuPathe, a public company focused on diseases of the central nervous system. Jane is also founder and former EVP of Auxilium, another public pharmaceutical company. Prior to that, Jane was VP & General Counsel of IBAH, a public multinational CRO. Before joining IBAH, Jane practiced law at Montgomery, McCracken, Walker & Rhoads in Philadelphia.
Scott DessainChief Scientific Officer
Dr. Dessain is an Associate Professor at the Lankenau Institute for Medical Research and Co-founder and Chief Scientific Officer of Immunome. He received his MD and PhD from Yale and post-graduate training at Brigham and Women's Hospital and Dana Farber Cancer Care. His post-doctoral training was with Dr. Robert Weinberg at the Whitehead Institute in Cambridge. Dr. Dessain was also an instructor at Massachusetts General Hospital and on the facul
Joel Sussman is a financial management consultant who serves in the capacity of CFO for early-stage companies. His present and former clients include numerous venture capital-backed life sciences companies – including Adolor, BioRexis, Cardiokine, Gentara, Neotropix and Valeo Medical. He also served as CFO and/or Treasurer of public and private technology and healthcare companies.
Kate Shay, Duane MorrisLawyerUnconfirmedGold Gocial Gerstein LLCAccountantUnconfirmed
BioAdvanceUnconfirmedMidAtlantic Venture GroupUnconfirmedWistar MorrisUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.